SCHEMBL21472228

SCHEMBL21472228

c1ccc(-c2ccc3c4ccc(-c5ccccc5)cc4n(-c4ccccc4-c4nc(-c5ccccc5)nc(-c5ccccc5-n5c6cc(-c7ccccc7)ccc6c6ccc(-c7ccccc7)cc65)n4)c3c2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.38
KMT2A Q03164 4/20 0.38
ALDH1A1 P00352 2/20 0.38
MAPT P10636 2/20 0.38
HPGD P15428 2/20 0.38
TSHR P16473 2/20 0.38
ADORA3 P0DMS8 1/20 0.38
ALOX15 P16050 1/20 0.38
ADORA2A P29274 1/20 0.38
ADORA2B P29275 1/20 0.38
ADORA1 P30542 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.36
NTSR1 P30989 1/20 0.35
DHFR P00374 1/20 0.35
LMNA P02545 2/20 0.35
POLB P06746 1/20 0.35
ATM Q13315 1/20 0.34
KDM4E B2RXH2 1/20 0.34
GLA P06280 1/20 0.34
AVPR2 P30518 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27252022 1.00 MEN1 (0.38) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL21472257 1.00 MEN1 (0.38) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL21472380 0.96 ALDH1A1 (0.37) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL21472259 0.96 ALDH1A1 (0.37) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL21472261 0.95 MEN1 (0.35) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL21472241 0.95 MEN1 (0.35) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL25932746 0.93 KMT2A (0.34) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL25932749 0.93 KMT2A (0.34) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL24361594 0.92 ALDH1A1 (0.35) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL24839389 0.92 ALDH1A1 (0.35) MEN1KMT2AALDH1A1MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190319196-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND NITROGEN-CONTAINING COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2019-10-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190319196-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND NITROGEN-CONTAINING COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE NUDC, EML4, SLC7A5 MEN1 3905/4885KMT2A 2020/4885ALDH1A1 2078/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.